Status:
COMPLETED
Optimizing Integrated PMTCT Services in Rural North-Central Nigeria
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Suspected Damage to Fetus From Viral Disease in the Mother
HIV
Eligibility:
All Genders
Phase:
NA
Brief Summary
Each year, an estimated 230,000 HIV-infected women in need of services for prevention of mother-to-child transmission of HIV (PMTCT) give birth in Nigeria, more than in any other nation in the world. ...
Detailed Description
The investigators propose a parallel cluster randomized trial to evaluate the effects of the intervention. Twelve primary and secondary level health care facilities in Niger State will be randomized t...
Eligibility Criteria
Inclusion
- HIV-infected women (and their infants) who present to ANC or delivery with unknown HIV status;
- HIV-infected women (and their infants) with previous history of ARV prophylaxis or treatment, but who are not on prophylaxis or treatment at the time of presentation for antenatal care or delivery.
Exclusion
- HIV-infected women with known status who are on ARV prophylaxis or treatment at the time of presentation to ANC.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
369 Patients enrolled
Trial Details
Trial ID
NCT01805752
Start Date
March 1 2013
End Date
June 1 2016
Last Update
November 2 2016
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
CHC Agwara
Agwara, Niger State, Nigeria
2
Rural Hospital
Auna, Niger State, Nigeria
3
MCH Chanchaga
Chanchaga, Niger State, Nigeria
4
NCWS Farin Doki
Farin Doki, Niger State, Nigeria